We also demonstrated that the effects of cN-II silencing are not specific to lung tumor cells, since in human astrocytoma ADF cells a partial constitutive cN-II silencing is followed by a decrease of cell proliferation and a shift toward an oxidative metabolism. This evidence concerns the gene NT5C2 and astrocytoma (excluding glioblastoma).